Article
A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
Journal of electrocardiology - 1 Jan 2000
Roston Thomas M, Guo Wenting, Krahn Andrew D, Wang Ruiwu, Van Petegem Filip, Sanatani Shubhayan, Chen S R Wayne, Lehman Anna
Abstract excerpt
BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion channelopathy usually caused by gain-of-function mutations ryanodine receptor type-2 (RyR2). Left ventricular non-compaction (LVNC) is an often genetic cardiomyopathy. A rare LVNC-CPVT overlap syndrome may be caused by exon 3 deletion in RyR2. We sought to characterize the phenotypic spectrum and molecular basis of a novel RyR2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.